The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhythmia detection algorithms. Data was also collected to characterize the ICM system related safety events.
Study Type
OBSERVATIONAL
Enrollment
727
Heart Center Research, LLC
Huntsville, Alabama, United States
ICM System-related Complication-free Rate at 30 Days Post-implant
Time frame: 30 days
ICM System-related Complication-free Rate at 12 Months Post-implant
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Northern Arizona Healthcare
Flagstaff, Arizona, United States
Arrythmia Research Group
Jonesboro, Arkansas, United States
Scripps Memorial Hospital
La Jolla, California, United States
Cardiology Associates Medical Group
Ventura, California, United States
Cardiac Arrhythmia Service
Boca Raton, Florida, United States
Tallahassee Memorial Hospital
Tallahassee, Florida, United States
St. Luke's Idaho Cardiology Associates
Boise, Idaho, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
...and 14 more locations